Skip to main content
. 2021 Jul 26;29(7):1040–1058. doi: 10.5551/jat.62970

Supplementary Table 5. Adjusted HRs (95% CIs) of incident stroke, IS and HS according to groups of 5-year changes in differential leukocyte counts.

Changes (×109/L) stroke Ischemic stroke Hemorrhagic stroke
Events/ Person-years HR (95% CI) Events/ Person-years HR (95% CI) Events/ Person-years HR (95% CI)
Neutrophil count change
Q1 (<–0.65) 109/14215 0.91 (0.71–1.18) 90/14156 0.99 (0.74–1.32) 19/13929 0.64 (0.35–1.18)
Q2–Q3 (–0.65 to 0.49) 218/28969 1.00 (ref ) 171/28823 1.00 (ref ) 47/28468 1.00 (ref )
Q4 (> 0.49) 134/14048 1.23 (0.99–1.53) 106/13971 1.24 (0.97–1.59) 28/13755 1.20 (0.75–1.92)
Lymphocyte count change
Q1 (<–0.56) 126/15457 1.03 (0.81–1.32) 97/15373 0.93 (0.70–1.23) 29/15173 1.59 (0.92–2.76)
Q2–Q3 (–0.56 to 0.07) 250/27512 1.00 (ref ) 169/27414 1.00 (ref ) 34/26994 1.00 (ref )
Q4 (> 0.07) 132/14312 1.30 (1.04–1.62) 101/14211 1.21 (0.94–1.55) 31/14035 1.75 (1.07–2.86)
Monocyte count change
Q1 (<–0.26) 54/6190 1.12 (0.79–1.59) 42/6155 1.08 (0.73–1.61) 12/6066 1.27 (0.60–2.70)
Q2–Q3 (–0.26 to 0) 167/25313 1.00 (ref ) 127/25205 1.00 (ref ) 40/24925 1.00 (ref )
Q4 (> 0) 59/6477 1.37 (1.01–1.86) 50/6450 1.54 (1.10–2.16) 9/6327 0.85 (0.41–1.76)
Eosinophil count change
Q1 (<–0.08) 32/4705 0.85 (0.55–1.31) 24/4680 0.78 (0.47–1.27) 8/4640 1.20 (0.49–2.97)
Q2–Q3 (–0.08 to 0.06) 212/29170 1.00 (ref ) 167/29047 1.00 (ref ) 45/28658 1.00 (ref )
Q4 (> 0.06) 36/4093 1.03 (0.72–1.49) 28/4071 0.99 (0.65–1.50) 8/4009 1.24 (0.58–2.67)

Abbreviation: CI, confidence interval; HR, hazard ratio.

HRs were adjusted for age, sex, BMI, education, smoking status, drinking status, physical activity, hypertension, diabetes mellitus, hyperlipidemia, family history of stroke, intake of antibiotics or aspirin, and baseline differential leukocyte counts.